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To identify and validate genes associated with bone mineral density (BMD), which is a prominent osteoporosis risk factor, we tested
379,319 SNPs in 1000 unrelated white U.S. subjects for associations with BMD. For replication, we genotyped the most signiﬁcant
SNPs in 593 white U.S. families (1972 subjects), a Chinese hip fracture (HF) sample (350 cases, 350 controls), a Chinese BMD sample
(2955 subjects), and a Tobago cohort of African ancestry (908 males). Publicly available Framingham genome-wide association study
(GWAS) data (2953 whites) were also used for in silico replication. The GWAS detected two BMD candidate genes, ADAMTS18 (ADAM
metallopeptidase with thrombospondin type 1motif, 18) and TGFBR3 (transforming growth factor, beta receptor III). Replication studies
veriﬁed the signiﬁcant ﬁndings by GWAS.We also detected signiﬁcant associations with hip fracture for ADAMTS18 SNPs in the Chinese
HF sample. Meta-analyses supported the signiﬁcant associations of ADAMTS18 and TGFBR3 with BMD (p values: 2.56 3 105 to 2.13 3
108; total sample size: n ¼ 5925 to 9828). Electrophoretic mobility shift assay suggested that the minor allele of one signiﬁcant
ADAMTS18 SNPmight promote binding of the TEL2 factor, whichmay repress ADAMTS18 expression. The data fromNCBI GEO expres-
sion proﬁles also showed that ADAMTS18 and TGFBR3 genes were differentially expressed in subjects with normal skeletal fracture
versus subjects with nonunion skeletal fracture. Overall, the evidence supports that ADAMTS18 and TGFBR3might underlie BMD deter-
mination in the major human ethnic groups.Osteoporosis (MIM 166710) is the most common meta-
bolic skeletal disease; it is estimated that over 200 million
people worldwide have osteoporosis.1 It is mainly charac-
terized by low bone mass and microarchitectural deteriora-
tion of bone tissue, with the consequent increase in
fragility and susceptibility to fractures.2 Bone mineral
density (BMD) has a high heritability, ~70%, and it is an
important measurable risk factor for osteoporotic fractures,
because these fractures can develop with even mild stress
and trauma when BMD has decreased to the threshold
point.3 Consequently, BMD is the predominant surrogate
phenotype used in studying osteoporosis.
So far, several genes for osteoporosis have been
established, mostly through the large-scale meta-analyses
launched by the GENOMOS consortium. The examples
include the associations of Estrogen Receptor-a (ESR1
[MIM 133430]) PvuII and XbaI SNPs with fracture risk, the
association between the Cdx2 polymorphism of Vitamin D
Receptor (VDR [MIM 601769]) and vertebral fracture risk,
the association between the Sp1 polymorphismofCollagen
Type I a-1 (COL1A1 [MIM 120150]) and BMD, and the
associations between Low Density Lipoprotein Receptor-388 The American Journal of Human Genetics 84, 388–398, March 1Related Protein 5 (LRP5 [MIM 603506]) SNPs and BMD.4–8
However, the majority of the genetic factors that inﬂuence
BMD variation remain unknown.9,10
The goal of this studywas to identify, by use of a genome-
wide association study (GWAS) and replication approaches,
genes inﬂuencing human BMD variation at the hip and
spine, the clinically most important skeletal sites. The clin-
ical characteristics of participants in ﬁve independent
cohorts—the white U.S. GWAS sample (n ¼ 1000), the
white U.S. family sample (n ¼ 1972), the Chinese hip
fracture (HF) sample (n ¼ 700), the Chinese BMD sample
(n ¼ 2995), and the Tobago cohort of African origin (n ¼
908men)—are described in Tables 1–5. Except for thewhite
U.S. family sample, all samples were population-based. The
publicly shared Framingham 550K GWAS data from the
family-based Framingham Osteoporosis Study (n ¼ 2953
white subjects) were also analyzed for the replication SNPs.
During the discovery phase, we carried out a GWAS
using the Affymetrix Gene Chip Human Mapping 500K
Array Set. We successfully genotyped a total of 379,319
single-nucleotide polymorphisms (SNPs) in the white
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Table 1. Characteristics of White U.S. GWAS Sample
Trait
Male Female
%50 years (n ¼ 250) >50 years (n ¼ 251) Premenopause (n ¼ 249) Postmenopause (n ¼ 250)
Age (years) 33.44 (9.66) 67.33 (6.74) 33.97 (8.45) 66.36 (5.67)
Height (cm) 180.00 (6.78) 175.67 (6.63) 165.38 (6.13) 162.22 (6.43)
Weight (kg) 88.03 (15.35) 90.04 (14.47) 70.74 (16.51) 71.71 (15.10)
Spine BMD (g/cm2) 1.054 (0.123) 1.085 (0.203) 1.045 (0.118) 0.944 (0.102)
Hip BMD (g/cm2) 1.066 (0.146) 1.010 (0.141) 0.953 (0.123) 0.861 (0.135)
n ¼ 1000, data are shown as mean (SD).U.S. for BMD analyses. The subject-recruitment proce-
dures, standard examinations of BMD and related pheno-
types, genotyping with Affymetrix 500K Array, genotyping
quality control, and SNP-exclusion procedures have been
detailed elsewhere.11–13 In the GWAS sample, the hip
and spine BMD data were adjusted by signiﬁcant covari-
ates, including age, sex, height, and weight, and analyzed
with allelic and haplotypic association tests (haplotype
trend regression [HTR]14) implemented in HelixTree
5.3.1. The association analyses were conducted in (1) the
total sample, (2) the male and female subgroups, (3) the
premenopausal white females, and (4) the postmenopausal
white females, each group analyzed separately.
Given the LD among SNPs across the whole genome,
the Bonferroni correction could be considered overly
conservative; therefore, we adopted the pointwise GWAS
signiﬁcance threshold proposed elsewhere,15 ~4.2 3
107. The genewise approach used in calculating this
threshold took into account recent estimates of the total
number of genes in the human genome. Because 20
GWA tests (men/women/total samples; hip/spine BMDs;
premenopausal/postmenopausal female samples; single-
SNP testing/sliding-window testing) were conducted, the
pointwise GWAS signiﬁcance threshold that we used here
was 2.1 3 108 (Bonferroni adjustment of 4.2 3 107).
EIGENSTRAT16 software was used for guarding against
spurious associations due to potential population stratiﬁ-
cation. The LD patterns of the implicated genes were
analyzed and plotted with the use of the Haploview
program17 with the HapMap data from the International
HapMap project. The FASTSNP program was used for pre-
dicting the function of the SNPs of interest.18
We used ﬁve independent samples for replication. The
ﬁrst was a white U.S. family sample comprising 1972 white
individuals, from 593 nuclear families, who were recruitedThe Ameand phenotyped in the sameway aswere those in thewhite
U.S. GWAS sample.11,12 Genotyping was performed by
KBioscience (Herts, UK) via the technology of competitive
allele-speciﬁc PCR (KASPar), which is detailed at the
company’s website. Five SNPs of interest (Table 6) were
successfully genotyped. The replication rate (duplicate
concordance rate) was 99.7% for the genotyping in the
white family sample, and the average call rate was 97.8%.
The second replication cohort was the Framingham
sample from the FraminghamOsteoporosis Study,19 which
has been detailed before.20,21 Genotype and phenotype
data were downloaded from the dbGaP database. Data
download and usage was authorized by the SHARe data-
access committee. We have the data on 2953 phenotyped
white subjects, 448 from the original cohort (160 men
and 288 women) and 2505 from the offspring cohort
(1114 men and 1391 women). The original-cohort partici-
pants had BMD measurements calculated via a dual X-ray
absorptiometry machine (Lunar DPX-L), performed at
the hip and spine during exam 24. The offspring-cohort
participants were scanned with the same machine at
exam 6 or 7. The Framingham sample was genotyped
with the use of approximately 550,000 SNPs (Affymetrix
500K mapping array plus Affymetrix 50K supplemental
array). The genotype data for the ﬁve SNPs of interest
(Table 6) were analyzed for BMD associations.
The third replication cohort was a Chinese HF sample,
recruited from Xi’an City and neighboring areas in China.
The sample consisted of 350 unrelated patients with oste-
oporotic HF and 350 unrelated controls without HF. The
subject recruitment and experimentation procedures
(including genotyping) have been described by Yang
et al.,13 who called the same cohort a ‘‘Chinese GWA
sample.’’ The genotype data for the four SNPs of interest
(Table 6) were analyzed for HF associations.Table 2. Characteristics of White U.S. Family Sample
Trait Sons (n ¼ 246) Daughters (n ¼ 895) Fathers (n ¼ 318) Mothers (n ¼ 513)
Age (years) 38.7 (11.0) 39.1 (10.3) 63.6 (9.9) 62.3 (10.6)
Height (cm) 179.1 (7.5) 164.8 (6.1) 176.3 (7.1) 162.5 (6.3)
Weight (kg) 90.1 (17.3) 71.7 (16.0) 90.7 (16.1) 73.14 (14.9)
Spine BMD (g/cm2) 1.06 (0.14) 1.05 (0.13) 1.06 (0.14) 0.97 (0.16)
Hip BMD (g/cm2) 1.06 (0.13) 0.97 (0.13) 1.01 (0.17) 0.88 (0.14)
n ¼ 1972, data are shown as mean (SD).rican Journal of Human Genetics 84, 388–398, March 13, 2009 389
The fourth replication sample, the Chinese BMD sample,
comprised 2955 Chinese adults living in Changsha City of
China. The subject-recruitment criteria were the same as
those adopted for the white U.S. samples. BMD was
measured with the same model Hologic 4500W machines
(Hologic, Bedford,MA,USA)under the same strict protocols
applied for the white U.S. samples. The coefﬁcient of varia-
tion (CV) values of the dual-energy X-ray absorptiometry
(DXA)measurements for hip and spine BMDswere approx-
imately 1.01% and 1.33%, respectively. Genotyping was
performed with the use of a primer-extension method,
withMALDI-TOFmass spectrometry for multiplexed geno-
typing of SNPs on a MassARRAY system, performed as
suggested by the manufacturer (Sequenom, San Diego,
CA) and well described by Braun et al.22 Four SNPs of
interest (Table 6) were successfully genotyped. The replica-
tion rate is 99.2%, and the average call rate is 97.2%.
The ﬁfth replication sample was the Tobago BMD
sample, comprising 908 men of West African ancestry
whowere randomly selected from a large population-based
study of BMD among 2501 men aged 40 and older on the
Caribbean island of Tobago.23 This sample was of West
African ancestry with low non-African admixture (6%
non-African).24 The detailed recruitment scheme and phe-
notyping procedures have been described elsewhere.23 The
two SNPs of interest (Table 6) were successfully genotyped
with the ﬂuorogenic 50-nuclease TaqMan allelic-discrimi-
nation assay system (Applied Biosystems, Foster City,
CA). The assays were performed under standard conditions
on a 7900HT real-time PCR instrument. All genotype calls
were determined by two independent investigators, and
only concordant calls were used. The genotyping con-
sensus rate, based on approximately 8% blind replicate
genotypes, was 99.7%. The average completeness of geno-
typing for the two markers was 98.3%.
Table 3. Characteristics of Chinese HF Sample
Case Control
Number 350 350
Sex ratio (M/F) 124/226 173/177
Age (years) 69.35 (7.41) 69.54 (6.09)
Weight (kg) 59.15 (12.05) 59.61 (10.84)
Height (cm) 162.84 (8.31) 159.41 (9.20)
n ¼ 700, data are shown as mean (SD).390 The American Journal of Human Genetics 84, 388–398, MarchIn all studies, informed consent was obtained from
participants and studies were approved by the local institu-
tional review boards or ethical committees.
Statistical analyses for replication samples involved the
following: (1) In the white U.S. family sample and the
Framingham Osteoporosis Study sample, we conducted
the family-based association test (FBAT)25 for the SNPs of
interest for their association with the BMD residuals
adjusted by signiﬁcant covariates, including age, sex,
height, and weight. (2) In the Chinese HF sample, the
genotype distributions of ADAMTS18 SNPs between frac-
ture and nonfracture groups were analyzed with logistic
regression models controlling for age, sex, height, and
weight as covariates. (3) In the Chinese BMD sample, the
statistical procedures were the same as those used for the
white U.S. GWAS sample. (4) In the Tobago cohort
comprising only men, SNPs were tested for association
with BMD via linear regression as a test for an additive asso-
ciation between the number of copies of the minor allele
and BMD. The models were adjusted for age, weight, and
height. Analyses were performed with SAS version 9.1
(SAS Institute, Cary, NC, USA). The magnitude and direc-
tion of SNP effects were estimated by a linear-regression
model for random samples and by a quantitative transmis-
sion-disequilibrium test (QTDT) for family samples.
Finally, the meta-analyses for the signiﬁcant SNPs from
(1) all of the three white BMD samples (white U.S. GWAS,
white U.S. family, and Framingham samples) and (2) all
of the ﬁve BMD samples from different ethnic origins
(GWAS, white U.S. family, Framingham, Chinese BMD,
and Tobago samples) were conducted, respectively, with
the weighted z score-based meta-analysis approach26,27
(weighted by the square root of the sample size of each
combining sample) used for quantiﬁcation of the overall
evidence for association with BMD variation.
The initial GWAS results were as follows: For the single-
SNP allelic analyses, we did not ﬁnd any signiﬁcant associ-
ationswithhip/spine BMD in either the totalGWAS sample
or the male subsample at the genome-wide threshold of
2.13 108. In females, although noGWAS-level signiﬁcant
association with BMD was found, the SNP rs11864477 in
the ADAMTS18 gene (ADAMmetallopeptidase with thrombo-
spondin type 1 motif, 18 [MIM 607512]) associated with
hip BMD (p¼ 4.173 107, Figure 1A, Table 6) at the closest
level to the genome-wide signiﬁcance threshold. In theTable 4. Characteristics of Chinese BMD Sample
Trait
Male Female
%50 years (n ¼ 1298) >50 years (n ¼ 139) Premenopause (n ¼ 1149) Postmenopause (n ¼ 369)
Age (years) 26.78 (4.53) 65.59 (8.59) 27.38 (6.30) 60.50 (8.02)
Height (cm) 169.92 (5.57) 166.95 (5.61) 158.71 (5.11) 156.26 (5.48)
Weight (kg) 63.37 (9.00) 70.22 (9.61) 51.40 (6.71) 59.70 (8.94)
Spine BMD (g/cm2) 0.98 (0.11) 0.94 (0.15) 0.94 (0.10) 0.82 (0.14)
Hip BMD (g/cm2) 0.98 (0.13) 0.91 (0.13) 0.88 (0.10) 0.81 (0.13)
n ¼ 2995, data are shown as mean (SD).13, 2009
sliding-window haplotype analyses, the most signiﬁcant
haplotype for spine BMDalmost hit theGWAS-signiﬁcance
cutoff. This haplotype was located in the TGFBR3 gene
(transforming growth factor, beta receptor III [MIM 600742])
(p ¼ 3.47 3 108; Figure 1B, Table 6).
We then analyzed the above two implicated genes in
more detail. In the female sample, as shown in Figure 2
and Table 6, three other ADAMTS18 gene SNPs, which
are near and in signiﬁcantly strong LD with rs11864477
(pairwise r2 > 0.90), were associated with hip BMD
(p values ¼ 2.03 3 106, 5.75 3 107, and 1.28 3 106
for rs11860781, rs16945612, and rs11859065, respec-
tively). These four SNPs were suggestive for hip BMD in
the total sample (p values ¼ 8.31 3 104, 3.84 3 103,
Table 5. Characteristics of Tobago Cohort of African Origin
Age (yr) 56.2 (9.6)
Height (cm) 175.5 (6.9)
Weight (kg) 84.47 (14.79)
Total body BMD (g/cm2) 1.27 (0.11)
Spine BMD (g/cm2) 1.12 (0.16)
Hip BMD (g/cm2) 1.15 (0.14)
Femoral neck BMD (g/cm2) 1.01 (0.15)
Trochanter BMD (g/cm2) 0.89 (0.13)
Intertrochanteric BMD (g/cm2) 1.34 (0.16)
Ward’s Triangle BMD (g/cm2) 0.85 (0.19)
n ¼ 908, all of which are men. Data are shown as mean (SD).The Ame1.98 3 103, and 1.66 3 103 for rs11864477,
rs11860781, rs16945612, and rs11859065, respectively).
Haplotype block 12, containing rs16945612, rs11864477,
and rs11859065, was suggestively signiﬁcant for hip
BMD in the female subgroup (p ¼ 9.95 3 106) and the
total sample (p ¼ 1.9 3 102) (Figure 2). In the male
sample, we detected a signiﬁcant haplotype window
that contained rs11860781 (highly correlated with
rs16945612, rs11864477, and rs11859065 [r2 > 0.8]) and
was suggestively associated with hip BMD (p ¼ 6 3
103). Analyses stratiﬁed by menopausal status showed
consistent results. All of these four highly correlated
SNPs were suggestively associated with hip BMD in the
postmenopausal white women (p values ¼ 2 3 103 for
all four SNPs) and in the premenopausal white women
(p ¼ 4 3 103 for rs11864477; p ¼ 6 3 103 for
rs16945612; p ¼ 1 3 102 for rs11860781 and
rs11859065). These data support the proposal that the
ADAMTS18 gene contributes to the variation of hip BMD.
For the TGFBR3 gene, we found that rs17131547 was
the key SNP for the most signiﬁcant haplotype window
(p ¼ 3.47 3 108 for spine BMD association), composed
of TGFBR3 SNPs—rs17131547, rs12403389, rs4658112,
rs17131544, and rs2087299. Several other haplotype
windows harboring rs17131547 were also suggestively
signiﬁcant for spine BMD (p values lie in [0.005, 0.05]).
Single-SNP analyses showed that rs17131547was suggestive
for spine BMD in the total sample (p¼ 3.913 104; Figure 3Table 6. Summary of Association Results in GWAS and Replication Studies
SNP
US White GWAS
Sample p Value
US White Family
Sample p Value
Framingham Sample
(White) p Value
Chinese HF
Sample p Value
Chinese BMD
Sample p Value
Tobago BMD Sample
(African) p Value
ADAMTS18
rs16945612
Hip BMD/female sample:
5.75 3 107 (allele)
4.61 3 104 (haplotype)
Hip BMD:
1.6 3 102Spine
BMD:3.5 3 103
Hip BMD: 6 3 103 Hip fracture:
1.9 3 102
Hip BMD:
9 3 103 Spine
BMD: 1 3 102
Hip BMD:
1.7 3 101 Trochanter
BMD: 3.2 3 102
ADAMTS18
rs11859065
Hip BMD/female sample:
1.28 3 106 (allele)
4.91 3 104 (haplotype)
Hip BMD:
1.65 3 102 Spine
BMD: 3.5 3 103
Hip BMD: 5.5 3 103 Hip fracture:
1.9 3 102
Hip BMD:
9 3 103 Spine
BMD: 1 3 102
NAa
ADAMTS18
rs11864477
Hip BMD/female sample:
4.17 3 107 (allele)
2.90 3 105 (haplotype)
Hip BMD:
1.65 3 102 Spine
BMD: 3.5 3 103
Hip BMD: 6.5 3 103 Hip fracture:
1.9 3 102
Hip BMD:
9 3 103 Spine
BMD: 1 3 102
NAa
ADAMTS18
rs11860781
Hip BMD/female sample:
2.03 3 106 (allele)
5.78 3 104 (haplotype)
Hip BMD: 1 3 102 Hip BMD: 1.0 3 102 Hip fracture:
1.7 3 101
Hip BMD: 1 3 101 NAa
TGFBR3
rs17131547
Spine BMD/total sample:
3.91 3 104 (allele)
3.47 3 108 (haplotype)
Spine BMD: 1 3 102 Spine BMD: 3 3 102 NAb NAb Spine BMD:
6.7 3 103 Total body
BMD: 3.1 3 102
Hip BMD: 1.1 3 103
Femoral Neck BMD:
5.4 3 103
Intertrochanter BMD:
4.93 3 104
Trochanter BMD:
1.3 3 102
Ward’s triangle BMD:
2.82 3 104
a rs11859065, rs11864477 and rs11860781 was not genotyped in Tobago sample considering the redundancy in genotyping since they are all in strong LD
with rs16945612 in the HapMap African sample.
b rs17131547 was monomorphic in Chinese.rican Journal of Human Genetics 84, 388–398, March 13, 2009 391
Figure 1. Genome-wide Association Results for BMD in the White U.S. GWAS Sample
(A) Genome-wide association results for hip BMD in the female sample by the single-SNP approach.
(B) Genome-wide association results for spine BMD in the total sample by the 5-SNP-size sliding-window approach.and Table 6), the male sample (p ¼ 4.27 3 103), and the
female sample (p ¼ 3.8 3 102). Interestingly, no adjacent
SNPs near rs17131547 were signiﬁcant for spine BMD
(Figure3 andTable S2, availableonline). LDanalyses showed
that rs17131547wasan independentSNPwithalmostnoLD
with any of the other typed SNPs in the TGFBR3 gene (pair-
wise r2 < 0.04), suggesting the independent association of
this SNP or a nearby untyped SNP with spine BMD. The
detailed information and association results for both
ADAMTS18andTGFBR3are summarized inTables S1andS2.392 The American Journal of Human Genetics 84, 388–398, March 1In the white U.S. GWAS sample, we compared raw BMD
values between the groups carrying different alleles of the
two most signiﬁcant BMD-associated SNPs. As shown in
Figure 4, subjects carrying the C allele of rs11864477 in
ADAMTS18 had a signiﬁcantly lower mean hip BMD value
than those carrying the alternative T allele (3% lower; raw
hip BMD values were 0.946 versus 0.975 g/cm2 for C versus
T alleles: p ¼ 0.006). Subjects carrying the A allele of
rs17131547 in TGFBR3 had a signiﬁcantly higher mean
spine BMD value than those carrying the G allele (5%3, 2009
Figure 2. Association Signals in the ADAMTS18 Gene in 16q23
(A) Genomic locations of chromosome 16q23 genes between 75873929 and 76026512 bp.
(B) The negative log10 p values from the female sample are plotted for genotyped markers in the ADAMTS18 region.
(C) Pairwise r2 plot for the genotype data of ADAMTS18 in this study. The intensity of shading is proportional to r2. The x axis represents
physical positions.
(D) Enlarged picture of the significant region in ADAMTS18. The numbers on the x axis are the SNP IDs corresponding to those in Table S1.higher; rawspineBMDvalueswere1.084versus1.032g/cm2
for A versus G alleles, p ¼ 0.029). It was also estimated that
in the initial GWAS sample, ADAMTS18 SNPs explained
3.77%–3.85% of hip BMD variation, whereas the TGFBR3
SNP explained 1.23% of spine BMD variation (Table 7).
In all of the replication samples, thedirections of SNPeffects
were the same as those in the white U.S. GWAS sample. The
effect sizes of the SNPs of interest in all of the replication
sampleswere smaller than those in thewhiteGWAS sample,
which could be explained by the weaker associations in the
replication samples.
Population stratiﬁcation was unlikely to be a key con-
founding factor inﬂuencing BMD associations in this
GWAS.This ismainlybecause the results fromEIGENSTRAT
analyses, controlling for potential population admixture or
stratiﬁcation, validated the signiﬁcant identiﬁed BMDasso-
ciations (for example, at locus rs11864477, p¼ 4.973 107
and 4.17 3 107 with and without EIGENSTRAT adjust-
ment, respectively; and lGC ¼ 1.011 for BMD phenotypes,
indicating no signiﬁcant population stratiﬁcation).
Quantile-quantile plots (Figure 5) revealed the presence
of a substantial number of SNPs associated with hip and
spine BMD. These results indicated that a substantial frac-The Ametion of the most strongly associated SNPs could have true
associations with BMD.
Replication studies veriﬁed the signiﬁcant ﬁndings of the
initialGWAS. In thewhiteU.S. family sample, the sameSNPs
were consistently associatedwith BMDvariation (p values¼
1.653 102 and 3.53 103 for hip and spine BMD associa-
tions, respectively, at three highly correlated ADAMTS18
SNP loci—rs16945612, rs11859065, and rs11864477; p ¼
1 3 102 for hip BMD association at rs11860781 in
ADAMTS18; and p ¼ 1 3 102 for spine BMD association
at rs17131547 in TGFBR3; Table 6). In silico replication,
again using Framingham data, showed that the four highly
correlated ADAMTS18 SNPs in whites—rs16945612,
rs11859065, rs11864477, and rs11860781—were associated
with hip BMD variation (p values ¼ 6 3 103, 5.5 3 103,
6.5 3 103, 1.0 3 102, respectively; Table 6), whereas
the TGFBR3 SNP, rs17131547, was associated with spine
BMD variation (p ¼ 33 102, Table 6).
In the Chinese HF sample, rs16945612, rs11859065 and
rs11864477, three completely correlated ADAMTS18 SNPs
(pairwise r2 ¼ 1), were signiﬁcantly associated with HF
(p values ¼ 1.9 3 102 for all; Table 6). In the Chinese
BMD sample, signiﬁcant associations with hip and spinerican Journal of Human Genetics 84, 388–398, March 13, 2009 393
Figure 3. Association Signals in the TGFBR3 Gene on the Chromosome Region 1p22
(A) Genomic locations of chromosome 1p22 genes between 91900000 and 92150000 bp.
(B) The negative log10 p values from the total sample are plotted for genotyped markers in the TGFBR3 region.
(C) Pairwise r2 plot for the genotype data of TGFBR3 in this study. The intensity of shading is proportional to r2. The x axis represents
physical positions.
(D) Enlarged picture of the significant region in TGFBR3. The numbers on the x axis are the SNP IDs corresponding to those in Table S2.BMD variations (p values ¼ 93 103 and 13 102, respec-
tively; Table 6) at the same three SNPs were also detected.
The signiﬁcanceofADAMTS18 andTGFBR3 toBMDpheno-
types was further replicated in the Tobago sample of West
African ancestry (ADAMTS18-rs16945612: p ¼ 3.2 3 102
for trochanter BMD; TGFBR3-rs17131547: p ¼ 6.7 3 103,
3.1 3 102, 1.1 3 103, 5.4 3 103, 4.9 3 104, 1.3 3
102, and 2.8 3 104 for BMD measured at lumbar spine,
total body, total hip, femoral neck, intertrochanter,
trochanter, and Ward’s triangle, respectively; Table 6). The
other three ADAMTS18 SNPs in signiﬁcant strong LD with
rs16945612 were not genotyped in the Tobago sample as
a result of local budgetary limits.
The data from the CEU, CHB, and YRI HapMap samples
were used to plot the LD blocks covering the four
ADAMTS18 SNPs of interest (Figures S1–S3). The HapMap
data corroborated that these four SNPs were highly corre-
lated in the white and black populations, whereas in the
Chinese populations, three of the four were highly corre-
lated (rs11860781 was independent of the other three
SNPs in Chinese populations).
Meta-analyses for (1) all of thewhiteBMDsamples and (2)
all of the BMD samples from different ethnic origins sup-394 The American Journal of Human Genetics 84, 388–398, March 1ported the above signiﬁcant associations (p values ranged
from 1.19 3 106 to 2.13 3 108 for hip BMD associations
at ADAMTS18 SNPs; p values ¼ 2.56 3 105 and 1.49 3
106 for spine BMD association at rs17131547 of TGFBR3).
The results of the meta-analyses are listed in Table 8.
The bioinformatics analyses suggested that the allele
change (T/C) at rs16945612 should generate one binding
site of TEL2 (ETS Transcription Factor TEL2 [MIM 605255]).
The enhanced TEL2 binding might repress ADAMTS18
expression, given that TEL2 has been identiﬁed as a tran-
scriptional repressor.28 Particularly, TEL2 has also been
shown to repress two genes (BMP-6 and RARa) that play
important roles in regulating osteoblast differentiation
and bone remodeling.28 Therefore, we conducted electro-
phoretic mobility shift assay (EMSA) to conﬁrm the poten-
tial changes of TEL2 binding to ADAMTS18 caused by
rs16945612. We made TEL2 protein preparations by trans-
forming the pGEX-2T construct29 into Escherichia coli
BL21 cells. Protein expression and extractions were per-
formed according to manufacturer’s instructions (Pharma-
cia, Peapack,NJ, USA). Protein concentrationwasmeasured
by the BCA Protein Assay kit (Pierce, Rockford, IL, USA),
with bovine serum albumin as a standard. The following3, 2009
double-stranded oligonucleotides were synthesized (Inte-
grated DNA Technologies, Coralville, IA, USA) and used
in EMSA: (1) the labeled wild-type TEL-2b binding-site
probe, corresponding to ADAMTS18 intron3 sequences
centering rs16945612 (underlined and bolded in the
following sequences), prepared by annealing of the digoxi-
genin (DIG)-labeled oligonucleotide 50-ACAACAACTTTA
TTTCTGGTCCAAG-30 with the complementary sequence
50-CTTGGACCAGAAATAAAGTTGTTGT-30; (2) the mut-
ant TEL-2b binding-site probe, prepared by annealing
the DIG-labeled oligonucleotide 50-ACAACAACTTTACT
Figure 4. Average Raw BMD Values for Groups Stratified by
Different Alleles at rs11864477 in ADAMTS18 and at
rs17131547 in TGFBR3
Error bars denote standard error.The AmeTCTGGTCCAAG-30 with the complementary sequences
50-CTTGGACCAGAAGTAAAGTTGTTGT-30; and (3) the
corresponding unlabeled mutant TEL2 binding-site probe.
EMSA was conducted with the DIG Gel Shift kit (Roche
Applied Science, Indianapolis, IN, USA). We incubated
0.8 ng of DIG-labeled probe with different amounts of
nuclear extracts (0–5.7 mg) for 30 min at room temperature
in a 10 ml reaction volume containing 2 ml binding buffer
(53), 1 mg poly [d(IA-T)], and 0.1 mg Poly L-lysine. For
competition reactions, we used the above unlabeled
mutant TEL2 binding-site probe and an unrelated oligonu-
cleotide for competition at 125-fold molar excess of the
labeled mutant TEL2 binding-site probe. For the supershift
assay, we incubated 2 mg of antibodies speciﬁc for TEL2
(named a-TEL2, purchased from Abcam, CA, USA) or 2 mg
of an irrelevant peptide (i.e., anti-goat IgG) with the
protein-DNA complex. After incubation, the samples were
separated by electrophoresis on a 6% nondenaturing poly-
acrylamide gel with 0.53 TBE buffer. DNA-protein
complexes were electroblotted to nylon membrane (Invi-
trogen, Carlsbad, CA, USA) and visualized by exposure to
Lumi-Film Chemiluminescent Detection Film (Roche).
Indeed, we found speciﬁc binding of TEL2 from E.coli
BL21 protein extract to the mutant TEL2 binding site
centering the rs16945612 minor allele ‘‘C’’ of ADAMTS18,
conﬁrmed by supershifting on addition of antibodies
against TEL2 (Figure 6). We found no binding of the
nuclear extract to the wild-type site containing the native
allele ‘‘T’’ of rs16945612 (Figure 6). The results indicate that
the T/C change at rs16945612 creates a new TEL2
binding site in the ADAMTS18 gene. In addition, the
NCBI GEO expression proﬁles showed that the ADAMTS18
level is signiﬁcantly lower in subjects with nonunionTable 7. Association Results in the White GWAS Sample
SNP Effect Sizea bb SEc Reference Allele
Hip BMD/ADAMTS18
Female sample (GWAS) rs16945612 0.03824 0.04428 0.01016 T
rs11859065 0.03826 0.04429 0.01016 G
rs11864477 0.03773 0.04353 0.01006 T
rs11860781 0.03848 0.04429 0.01013 A
Combined white family sampled rs16945612 0.01 0.058 - T
rs11860781 0.01 0.048 - A
Chinese BMD sample rs16945612 0.0025 0.06898 0.03108 T
rs11860781 0.00045 0.0201 0.0209 A
Tobago BMD sample rs16945612 0.00332 0.06131 0.0374 T
Spine BMD/TGFBR3
Total sample (GWAS) rs17131547 0.01231 0.4974 0.1442 G
Combined white family sampled rs17131547 0.012 0.058 - G
Tobago BMD sample rs17131547 0.0025 0.0673 0.044 G
Magnitude and Direction of SNP effects obtained by linear regression analyses (for random samples) and QTDT (for family samples).
a Effect size measured by r2.
b b: Regression coefficient.
c SE denotes standard error.
d The effect size and direction of an interested SNP were estimated in the combined white family sample consisting of i) white U.S. family sample and ii)
Framingham sample; SE of b cannot be estimated in the family samples due to the limitation of QTDT; for simplicity, the results for rs11859065 and
rs11864477 were not shown in the replication samples because they were the same with the results of rs16945612 due to their high correlations.rican Journal of Human Genetics 84, 388–398, March 13, 2009 395
fractures (fracture that does not heal six months after
injury) as compared to subjects with normal-healing frac-
tures (Figure S4). Decreased in vivo ADAMTS18 expression
might thus potentially contribute to the nonhealing of
skeletal fractures. The functional evidence, together with
the statistical evidence, lead us to hypothesize that allele
‘‘C’’ of rs16945612 might, through enhanced TEL2
binding, represses the expression of ADAMTS18 and subse-
quently inﬂuence the osteoporosis phenotypes.
TGFBR3 is the major mediator of TGF-b signaling
pathways30,31 and also functions as a BMP cell-surface
Figure 5. Quantile-Quantile Plots for Hip BMD and Spine BMD
Associations
(A) Quantile-quantile plots for hip BMD associations in the GWAS
female sample.
(B) Quantile-quantile plots for spine BMD associations in the GWAS
total sample.
Axes represent the following information: y axis, observed
–log10(p) values; x axis, p values expected under the null distribu-
tion for the GWAS SNPs.396 The American Journal of Human Genetics 84, 388–398, March 1receptor.32 Particularly, TGFBR3 can modulate the biolog-
ical function of BMP2 (bone morphogenetic protein 2
[MIM 112261]),32 which is a well-established key factor
in bone biology and is signiﬁcantly associated with BMD
and other bone phenotypes.33 Moreover, TGFBR3
knockout mice (TBRIII/) demonstrated severe abnormal
skeleton defects, as reported previously34 and detailed in
the MGI database of The Jackson Laboratory.
Interestingly, the NCBI GEO expression proﬁles showed
that TGFBR3 level is signiﬁcantly lower in normal skeletal
fracture subjects as compared to nonunion skeletal fracture
subjects (Figure S5). This is opposite of the expression
pattern for ADAMTS18 (Figure S4), suggesting different
physiological roles for these two genes in the healing of
bone fractures.
In summary, the present GWAS and multiple replication
studies identiﬁed two genes, ADAMTS18 and TGFBR3, that
were signiﬁcantly associated with BMD variation in three
major ethnic groups. The results of these studies direct
attention to these two genes, which have not been well
studied previously in the ﬁeld of osteoporosis research.
Additional molecular studies are required for deﬁning the
precise and detailedmechanisms by which these two genes
contribute to BMD and osteoporosis risk.
Supplemental Data
Supplemental Data include two tables and ﬁve ﬁgures and can be
found with this article online at http://www.ajhg.org/.
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Table 8. Results of Meta-Analyses Using the Weighted z Score-Based Approach
SNP p Value of All White BMD Samples Combineda p Value of All BMD Samples combinedb
ADAMTS18:rs16945612 Hip BMD:2.84 3 107 Hip BMD:2.13 3 108
ADAMTS18:rs11859065 Hip BMD:3.57 3 107 Hip BMD:3.13 3 108
ADAMTS18:rs11864477 Hip BMD:2.75 3 107 Hip BMD:2.48 3 108
ADAMTS18:rs11860781 Hip BMD:5.37 3 107 Hip BMD:1.19 3 106
TGFBR3:rs17131547 Spine BMD:2.56 3 105 Spine BMD:1.49 3 106
The z score is weighted by the square root of the sample size of each combining sample.
a Including white U.S. GWAS, white U.S. family and Framingham samples (whites). N ¼ 5925.
b Including white U.S. GWAS, white U.S. family, Framingham sample, Chinese BMD and Tobago BMD samples for ADAMTS18 SNPs - rs16945612; including
white U.S. GWAS, white U.S. family, Framingham sample, and Chinese BMD sample for the other three ADAMTS18 SNPs that were not genotyped in Tobago
sample; while including white U.S. GWAS, white U.S. family, Framingham sample, and Tobago BMD sample for TGFBR3 - rs17131547, which is monomorphic
in Chinese. N ¼ 9,828 for ADAMTS18 SNPs - rs16945612; N ¼ 8,920 for other ADAMTS18 SNPs; N ¼ 6833 for the TGFBR3 SNP.Mouse Genome Informatics, http://www.informatics.jax.org
NCBI GEO expression database, http://www.ncbi.nlm.nih.gov/
geo
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim/
QTDT program, http://www.sph.umich.edu/csg/abecasis/QTDT
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